- Home
- ADTN vs SVRA Comparison
ADTN vs SVRA Comparison
Compare ADTN & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADTN | SVRA |
|---|---|---|
| Founded | 1985 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 1996 | 2009 |
Fundamental Metrics
Financial Performance| Metric | ADTN | SVRA |
|---|---|---|
| Price | $13.44 | $6.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $15.50 | $7.33 |
| AVG Volume (30 Days) | 1.9M | ★ 2.0M |
| Earning Date | 05-04-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 90.83 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,083,807,000.00 | N/A |
| Revenue This Year | $11.09 | N/A |
| Revenue Next Year | $8.47 | $430.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 17.46 | N/A |
| 52 Week Low | $7.11 | $2.25 |
| 52 Week High | $19.98 | $7.01 |
Technical Indicators
Market Signals| Indicator | ADTN | SVRA |
|---|---|---|
| Relative Strength Index (RSI) | 43.32 | 58.79 |
| Support Level | $8.72 | $5.86 |
| Resistance Level | $18.34 | $6.15 |
| Average True Range (ATR) | 0.75 | 0.29 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 31.04 | 56.92 |
Price Performance
Historical ComparisonAbout ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.
About SVRA Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).